Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
14.60
-0.51 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
14.88
+0.28 (1.92%)
After-hours: Apr 28, 2026, 4:56 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $859.62 million as of April 28, 2026. Its market cap has increased by 3,954.82% in one year.
Market Cap
859.62M
Enterprise Value
762.06M
1-Year Change
3,954.82%
Ranking
Category
Stock Price
$14.60
Market Cap Chart
Since January 15, 2010, Tenax Therapeutics's market cap has increased from $148.50M to $859.62M, an increase of 478.87%. That is a compound annual growth rate of 11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 259.90M | 241.52% |
| Dec 31, 2025 | 76.10M | 260.66% |
| Dec 31, 2024 | 21.10M | 219.70% |
| Dec 29, 2023 | 6.60M | 32.00% |
| Dec 30, 2022 | 5.00M | -80.92% |
| Dec 31, 2021 | 26.20M | 11.49% |
| Dec 31, 2020 | 23.50M | 147.37% |
| Dec 31, 2019 | 9.50M | 427.78% |
| Dec 31, 2018 | 1.80M | -86.96% |
| Dec 29, 2017 | 13.80M | -74.82% |
| Dec 30, 2016 | 54.80M | -40.63% |
| Dec 31, 2015 | 92.30M | -14.54% |
| Dec 31, 2014 | 108.00M | 125.94% |
| Dec 31, 2013 | 47.80M | 123.36% |
| Dec 31, 2012 | 21.40M | -45.69% |
| Dec 30, 2011 | 39.40M | -10.86% |
| Dec 31, 2010 | 44.20M | -70.24% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 786.19M |
| Solid Biosciences | 779.29M |
| Design Therapeutics | 772.75M |
| Relmada Therapeutics | 756.24M |
| Vor Biopharma | 748.30M |
| Alpha Tau Medical | 712.00M |
| Lexicon Pharmaceuticals | 711.78M |
| BridgeBio Oncology Therapeutics | 702.69M |